The impact of risk anomalies on the pharmaceutical sector of the indian stock market: A comparative analysis between pharmaceutical, FMCG and IT companies

Abstract

The main purpose of this research article is to provide a comparative framework on various implications of risk anomalies on Indian stock market based on an empirical study for the following sectors: Pharmaceutical, Fast-Moving Consumer Goods (FMCG) and IT. Risk anomaly is a notable anomaly because it is continual and all-inclusive. This research study aims to examine the existence of risk anomaly in the National Stock Exchange, India, and in particular providing a comparative analysis on the behavior of the pharmaceutical sector in India.